Human Breast Milk Extracellular Vesicles Mitigate Endothelial Dysfunction
Nutrients · 2025
DOI: 10.3390/nu17182953 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Young-Eun Cho und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Nursing, The University of Iowa, Iowa City, IA 52242, USA. Hauptthemen laut MEDLINE: Extracellular Vesicles, Milk, Human, Endothelium, Vascular. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fraternal Order of Eagles, Fraternal Order of Eagles Diabetes Research Center.
Abstract (Originalsprache)
Background
Endothelial cell (EC) dysfunction is an early sign of compromised vascular integrity and is associated with various cardiovascular diseases (CVDs). Activation of Toll-like receptor 4 (TLR4) plays a central role in this process. Extracellular vesicles (EVs) derived from milk have known anti-inflammatory properties, particularly in suppressing TLR4 activation. This study investigates the therapeutic potential of human breast milk-derived EVs (HBM-EVs) in mitigating EC dysfunction related to CVDs.
Methods
HBM-EVs were isolated from the breast milk of healthy nursing mothers using ultracentrifugation. HBM-EVs were applied to lipopolysaccharide (LPS)-treated human umbilical vein endothelial cells (HUVECs), and inflammatory marker expression was assessed through qPCR and Western blotting. Mitochondrial oxidative stress was measured using MitoSOX. The effects of HBM-EVs were further evaluated in ex vivo studies using mesenteric arteries from diet-induced obese mice. Additionally, the effect of HBM-EVs on angiogenesis was tested via a wound closure assay.
Results
In HUVECs, pre-treatment with HBM-EVs inhibited LPS-induced expression of inflammatory markers, including IL-6 and VCAM-1, as well as the phosphorylation of NFκB. Additionally, HBM-EVs reduced LPS-induced mitochondrial oxidative stress. In animal studies, HBM-EV treatment restored EC-dependent vasorelaxation in mesenteric arteries from diet-induced obese mice. Furthermore, HBM-EVs enhanced EC migration, leading to improved wound closure in HUVECs.
Conclusion
This study demonstrates the therapeutic potential of HBM-EVs in alleviating EC dysfunction, offering a promising new approach to the treatment of CVDs. Future research will focus on identifying the specific cargo of HBM-EVs and further exploring their therapeutic mechanisms in endothelial dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Nursing, The University of Iowa, Iowa City, IA 52242, USA.
- Stead Family Department of Pediatrics, Carver College of Medicine, The University of Iowa, Iowa City, IA 52242, USA.
ORCID-Profile: Young-Eun Cho, Brajesh K Singh
Förderung
- Fraternal Order of Eagles
- Fraternal Order of Eagles Diabetes Research Center
Zitieren
APA
Cho, Y. E., Chen, S., Crouch, K., Shutt, D., Kaufman, J. W., & Singh, B. K. (2025). Human Breast Milk Extracellular Vesicles Mitigate Endothelial Dysfunction. Nutrients. https://doi.org/10.3390/nu17182953
Vancouver
Cho YE, Chen S, Crouch K, Shutt D, Kaufman JW, Singh BK. Human Breast Milk Extracellular Vesicles Mitigate Endothelial Dysfunction. Nutrients. 2025. doi:10.3390/nu17182953
BibTeX
@article{Cho2025,
author = {Cho, Young-Eun and Chen, Shaoshuai and Crouch, Keith and Shutt, Damon and Kaufman, Justin W and Singh, Brajesh K},
title = {Human Breast Milk Extracellular Vesicles Mitigate Endothelial Dysfunction},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17182953}
}
EUVIMED